- Question
- For adults, how do medications, psychological therapies and brain stimulation compare?
- Study design
- Systematic review and component network meta-analysis of randomised trials in adults.
- Participants
- Adults with ADHD across a large set of randomised trials.
- What researchers found
- Only stimulants and atomoxetine consistently reduced core symptoms on both self- and clinician-rated scales in the short term. Psychological and other non-drug interventions had inconsistent effects. Evidence on quality of life and long-term outcomes was limited.
- What this DOES mean
- For adults, the strongest current evidence for reducing core symptoms is for medication, in the short term.
- What this DOESN’T mean
- It doesn’t mean therapy is useless. Many therapy trials are small and very different from each other, which makes clear effects hard to detect. Nor does it mean medication improves quality of life.
- Limitations
- Mixing very different therapies makes comparisons hard; few long-term trials exist.
- Evidence level
- Strong, replicated evidence — usually meta-analyses or international consensus. Unlikely to change much. What these labels mean
- Original source
- Meta-analysis Ostinelli EG, et al. (senior author: Cortese S) (2025). Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. The Lancet Psychiatry. Open source ↗Adults only. Short-term symptom benefits for stimulants and atomoxetine; little evidence on quality of life or long-term outcomes.
What these labels mean